Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.440.02%
QQQ
715.040.02%
BTC/USD
77086.810.2437%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Vera Therapeutics Inc (VERA) Stock Price, Quote, News & History

VERANASDAQ
Trade with Public
Trade with Public
$35.05
1.454.32%
At close: Sep 11, 5:00 PM EST
$35.00
-0.05-0.14%
After Hours: Sep 11, 4:47 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Vera Therapeutics (VERA) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$33.91
Close
$35.05
Volume / Avg.
3.80M / 2.11M
Day Range
$33.75 - $35.29
52 Wk Range
22.72 - 56.05
Market Cap
$2.51B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
31.53%
Days to Cover
10.81

Recent Vera Therapeutics, Inc. News

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.
Avi Kapoor

Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday

U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
Avi Kapoor

Kura Sushi Posts Weak Q3 Sales, Joins FuelCell Energy And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-expected sales. Other stocks also decline in pre-market.
Avi Kapoor

Why Is Vera Therapeutics Stock Gaining Tuesday?

Vera Therapeutics (VERA) stock jumps 9% following FDA accelerated approval for its kidney disease drug Trutakna. Full analysis here.
Vandana Singh

What's Going on with Vera Therapeutics Stock on Monday?

Vera Therapeutics awaits the FDA's July 7 decision on atacicept for IgA nephropathy as investors weigh trial data and competition from Novartis.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-338.65M
Investing Cash Flow (TTM)
45.47M
Financing Cash Flow (TTM)
292.94M
Free Cash Flow (TTM)
-339.18M
Capital Expenditure (TTM)
-522.00K
Net Change in Cash (TTM)
-245.00K

Analyst Trends and Forecast

1
May
4
1
Jul
1
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.10B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
5.93
Earnings Yield % (TTM)
-17.49%
Earnings Yield % (FWD)
-13.05%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.66

Company Debt

Total Debt
$75.23M
LT Debt
$75.23M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$48.88M
Debt to Equity
0.19
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
$33.91
Close
$35.05
Volume / Avg.
3.80M / 2.11M
Day Range
$33.75 - $35.29
52 Wk Range
22.72 - 56.05
Market Cap
$2.51B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
31.53%
Days to Cover
10.81

About

Sector
Health Care
Industry
Biotechnology
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vera Therapeutics (VERA) stock?

A

You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vera Therapeutics (VERA) competitors?

Q

What is the forecast, or price target, for Vera Therapeutics (VERA) stock?

A

Vera Therapeutics has a consensus price target of $67.81.

Q

What is the current price for Vera Therapeutics (VERA)?

A

The stock price for Vera Therapeutics (NASDAQ: VERA) is $35 last updated September 11, 2026 at 4:47 PM EDT.

Q

Does Vera Therapeutics (VERA) pay a dividend?

A

There are no upcoming dividends for Vera Therapeutics.

Q

When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?

A

Vera Therapeutics does not have any upcoming earnings scheduled.

Q

Is Vera Therapeutics (VERA) going to split?

A

There is no upcoming split for Vera Therapeutics.

Q

What sector and industry does Vera Therapeutics (VERA) operate in?

A

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved